Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in AVIR — Atea Pharmaceuticals, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to AVIR Full portfolio

Position in AVIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$63,751
-$376,521 QoQ
Shares Held
13,710
-83.2% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 124 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVIR Over Time

Shares Held

Position Value (USD)

Derivatives in AVIR

reported options exposure · as of Jun 30, 2026
CallValue
$52,080
CallShares
11,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. AVIR ranks #284 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in AVIR

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $52,080 11,200
2026-06-30 $63,751 13,710
2026-03-31 $440,272 81,835
2026-03-31 $418,026 77,700
2025-12-31 $61,246 17,156
2025-09-30 $144,112 49,694
2025-09-30 $106,430 36,700
2025-09-30 $66,410 22,900
2025-06-30 $592,279 164,522
2025-03-31 $315,696 105,584
2024-12-31 $172,715 51,557
2024-12-31 $65,995 19,700
2024-09-30 $178,111 53,168
2024-09-30 $325,955 97,300
2024-06-30 $228,390 69,000
2024-06-30 $223,577 67,546
2024-06-30 $594,145 179,500
2024-03-31 $749,059 185,411
2024-03-31 $381,376 94,400
2024-03-31 $745,380 184,500
2023-12-31 $89,670 29,400
2023-12-31 $54,595 17,900
2023-12-31 $162,699 53,344
2023-09-30 $653,622 217,874
2023-09-30 $30,000 10,000
2023-06-30 $1,141,765 305,285
2023-06-30 $126,412 33,800
2023-03-31 $621,279 185,457
2022-12-31 $157,306 32,704
2022-12-31 $2,738,814 569,400
2022-12-31 $117,845 24,500
2022-09-30 $3,245,576 570,400
2022-09-30 $237,273 41,700
2022-09-30 $120,741 21,220
2022-06-30 $343,753 48,416
2022-06-30 $3,454,860 486,600
2022-06-30 $254,180 35,800
2022-03-31 $977,588 135,400
2022-03-31 $307,636 42,609
2022-03-31 $496,014 68,700
2021-12-31 $98,447 11,012
2021-12-31 $648,150 72,500
2021-12-31 $2,766,930 309,500
2021-09-30 $2,457,706 70,100
2021-09-30 $2,746,495 78,337
2021-09-30 $3,169,424 90,400
2021-06-30 $332,940 15,500
2021-06-30 $2,042,748 95,100
2021-06-30 $1,518,636 70,700
2021-03-31 $1,568,450 25,400

Report a Problem

Category
Description
Email (optional, for follow-up)